{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T15:01:41Z","timestamp":1790780501938,"version":"4.1.0"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T00:00:00Z","timestamp":1662076800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Ketogenic dietary therapy (KDT) is used as an effective treatment for epilepsy. However, KDT carries the risk of bone health deterioration; therefore, vitamin D supplementation is required. Vitamin D replacement therapy in KDT has not been established because it may be related to hypercalciuria\/urolithiasis, which are common adverse effects of KDT. Hence, this study aimed to evaluate the dose-dependent association between vitamin D<jats:sub>3<\/jats:sub> and hypercalciuria\/urolithiasis in patients undergoing KDT and dose optimization for renal complications.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and methods<\/jats:title><jats:p>Overall, 140 patients with intractable childhood epilepsy started 3:1 KDT (lipid to non-lipid ratio) at the Severance Children\u2019s Hospital from January 2016 to December 2019. Regular visits were recommended after KDT initiation. Participants were assessed for height, weight, serum 25-hydroxyvitamin D (25-OH-D<jats:sub>3<\/jats:sub>) level, parathyroid hormone level, and ratio of urinary excretion of calcium and creatinine (Uca\/Ucr). Kidney sonography was conducted annually. Patients who already had urolithiasis and were taking hydrochlorothiazide before KDT, failed to maintain KDT for 3 months, did not visit the pediatric endocrine department regularly, did not take prescribed calcium and vitamin D3 properly, or needed hospitalization for &amp;gt; 1\u00b0month because of serious medical illness were excluded. Data from patients who started diuretic agents, e.g., hydrochlorothiazide, were excluded from that point because the excretion of calcium in the urine may be altered in these patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Result<\/jats:title><jats:p>In total, 49 patients were included in this study. Uca\/Ucr ratio significantly decreased with increasing levels of 25-OH-D<jats:sub>3<\/jats:sub> (<jats:italic>p<\/jats:italic> = 0.027). The odds ratio for hypercalciuria was 0.945 (95% confidence interval, 0.912\u20130.979; <jats:italic>p<\/jats:italic> = 0.002) per 1.0 ng\/mL increment in 25-OH-D<jats:sub>3<\/jats:sub> level. Based on findings of receiver operating characteristic curve analysis and Youden\u2019s J statistic, the cut-off 25-OH-D<jats:sub>3<\/jats:sub> level for preventing hypercalciuria was &amp;gt; 39.1 ng\/mL at 6 months. Furthermore, the vitamin D<jats:sub>3<\/jats:sub> supplementation dose cut-off was &amp;gt; 49.5 IU\/kg for hypercalciuria prevention.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>An inverse relationship between Uca\/Ucr ratio and 25-OH-D<jats:sub>3<\/jats:sub> level was noted, which means that vitamin D supplementation is helpful for preventing hypercalciuria related to KDT. We suggest that the recommended 25-OH-D<jats:sub>3<\/jats:sub> level is &amp;gt; 40 ng\/mL for hypercalciuria prevention and that KDT for children with epilepsy can be optimized by vitamin D<jats:sub>3<\/jats:sub> supplementation at 50 IU\/kg.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fnut.2022.970467","type":"journal-article","created":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T05:07:11Z","timestamp":1662095231000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Association of hypercalciuria with vitamin D supplementation in patients undergoing ketogenic dietary therapy"],"prefix":"10.3389","volume":"9","author":[{"given":"Myeongseob","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hae In","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyungchul","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han Saem","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junghwan","family":"Suh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se Hee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Wook","family":"Chae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoon-Chul","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joon Soo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heung Dong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho-Seong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahreum","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/epi4.12225","article-title":"Optimal clinical management of children receiving dietary therapies for epilepsy: updated recommendations of the International Ketogenic Diet Study Group.","volume":"3","author":"Kossoff","year":"2018","journal-title":"Epilepsia Open."},{"key":"B2","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/j.1528-1167.2007.00915.x","article-title":"Anticonvulsant mechanisms of the ketogenic diet.","volume":"48","author":"Bough","year":"2007","journal-title":"Epilepsia."},{"key":"B3","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/WCO.0000000000000432","article-title":"New insights into the mechanisms of the ketogenic diet.","volume":"30","author":"Boison","year":"2017","journal-title":"Curr Opin Neurol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1111\/j.0013-9580.2004.10004.x","article-title":"Early- and late-onset complications of the ketogenic diet for intractable epilepsy.","volume":"45","author":"Kang","year":"2004","journal-title":"Epilepsia."},{"key":"B5","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s004670000443","article-title":"Risk factors for urolithiasis in children on the ketogenic diet.","volume":"15","author":"Furth","year":"2000","journal-title":"Pediatr Nephrol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"F1243","DOI":"10.1152\/ajprenal.00211.2016","article-title":"Genetic, pathophysiological, and clinical aspects of nephrocalcinosis.","volume":"311","author":"Oliveira","year":"2016","journal-title":"Am J Physiol Renal Physiol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1046\/j.1523-1755.2003.00316.x","article-title":"Urine calcium and volume predict coverage of renal papilla by Randall\u2019s plaque.","volume":"64","author":"Kuo","year":"2003","journal-title":"Kidney Int."},{"key":"B8","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.juro.2012.05.078","article-title":"Reactive oxygen species as the molecular modulators of calcium oxalate kidney stone formation: evidence from clinical and experimental investigations.","volume":"189","author":"Khan","year":"2013","journal-title":"J Urol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"3155","DOI":"10.1097\/01.asn.0000099380.18995.f7","article-title":"Calcium oxalate crystal adherence to hyaluronan-, osteopontin-, and CD44-expressing injured\/regenerating tubular epithelial cells in rat kidneys.","volume":"14","author":"Asselman","year":"2003","journal-title":"J Am Soc Nephrol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1046\/j.1528-1157.2002.11302.x","article-title":"Kidney stones, carbonic anhydrase inhibitors, and the ketogenic diet.","volume":"43","author":"Kossoff","year":"2002","journal-title":"Epilepsia."},{"key":"B11","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s00240-010-0349-3","article-title":"A hypothesis of calcium stone formation: an interpretation of stone research during the past decades.","volume":"39","author":"Tiselius","year":"2011","journal-title":"Urol Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.3945\/ajcn.116.134981","article-title":"Hypercalcemia, hypercalciuria, and kidney stones in long-term studies of vitamin D supplementation: a systematic review and meta-analysis.","volume":"104","author":"Malihi","year":"2016","journal-title":"Am J Clin Nutr."},{"key":"B13","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s11255-018-1965-z","article-title":"Vitamin D and calcium kidney stones: a review and a proposal.","volume":"51","author":"Tavasoli","year":"2019","journal-title":"Int Urol Nephrol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1001\/jamapediatrics.2015.1419","article-title":"Current trends, evaluation, and management of pediatric nephrolithiasis.","volume":"169","author":"Hernandez","year":"2015","journal-title":"JAMA Pediatr."},{"key":"B15","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1056\/NEJMra070553","article-title":"Vitamin D deficiency.","volume":"357","author":"Holick","year":"2007","journal-title":"N Engl J Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1007\/s12519-017-0053-2","article-title":"Safety and tolerability of the ketogenic diet used for the treatment of refractory childhood epilepsy: a systematic review of published prospective studies.","volume":"13","author":"Cai","year":"2017","journal-title":"World J Pediatr."},{"key":"B17","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/ki.2008.626","article-title":"Recent advances in the pathophysiology of nephrolithiasis.","volume":"75","author":"Sakhaee","year":"2009","journal-title":"Kidney Int."},{"key":"B18","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1056\/NEJMcp1001011","article-title":"Clinical practice. Calcium kidney stones.","volume":"363","author":"Worcester","year":"2010","journal-title":"N Engl J Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1152\/physrev.00003.2004","article-title":"Calcium absorption across epithelia.","volume":"85","author":"Hoenderop","year":"2005","journal-title":"Physiol Rev."},{"key":"B20","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1210\/jcem-35-2-261","article-title":"Gastrointestinal calcium absorption in nephrolithiasis.","volume":"35","author":"Pak","year":"1972","journal-title":"J Clin Endocrinol Metab."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00240-010-0276-3","article-title":"An assessment of parathyroid hormone, calcitonin, 1,25 (OH)2 vitamin D3, estradiol and testosterone in men with active calcium stone disease and evaluation of its biochemical risk factors.","volume":"39","author":"Shakhssalim","year":"2011","journal-title":"Urol Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3390\/nu9030301","article-title":"Association between circulating Vitamin D level and urolithiasis: a systematic review and meta-analysis.","volume":"9","author":"Hu","year":"2017","journal-title":"Nutrients."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1093\/ajcn\/87.6.1952","article-title":"Vitamin D intake to attain a desired serum 25-hydroxyvitamin D concentration.","volume":"87","author":"Aloia","year":"2008","journal-title":"Am J Clin Nutr."},{"key":"B24","doi-asserted-by":"publisher","first-page":"829","DOI":"10.2215\/CJN.11331111","article-title":"Effect of vitamin D repletion on urinary calcium excretion among kidney stone formers.","volume":"7","author":"Leaf","year":"2012","journal-title":"Clin J Am Soc Nephrol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.juro.2016.08.084","article-title":"Vitamin D intake and the risk of incident kidney stones.","volume":"197","author":"Ferraro","year":"2017","journal-title":"J Urol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.urology.2015.10.009","article-title":"Idiopathic calcium nephrolithiasis and Hypovitaminosis D: a case-control study.","volume":"87","author":"Ticinesi","year":"2016","journal-title":"Urology."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1007\/s11255-016-1290-3","article-title":"Analysis of vitamin D deficiency in calcium stone-forming patients.","volume":"48","author":"Gir\u00f3n-Prieto","year":"2016","journal-title":"Int Urol Nephrol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1210\/jc.2011-0385","article-title":"Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline.","volume":"96","author":"Holick","year":"2011","journal-title":"J Clin Endocrinol Metab."},{"key":"B29","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1093\/ajcn\/84.1.18","article-title":"Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes.","volume":"84","author":"Bischoff-Ferrari","year":"2006","journal-title":"Am J Clin Nutr."},{"key":"B30","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s11154-021-09679-5","article-title":"Vitamin D, infections and immunity.","volume":"23","author":"Ismailova","year":"2022","journal-title":"Rev Endocr Metab Disord."},{"key":"B31","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3389\/fphys.2014.00122","article-title":"The future of vitamin D analogs.","volume":"5","author":"Leyssens","year":"2014","journal-title":"Front Physiol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"244","DOI":"10.3389\/fphys.2014.00244","article-title":"Vitamin D in inflammatory diseases.","volume":"5","author":"Wobke","year":"2014","journal-title":"Front Physiol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1172\/JCI15219","article-title":"1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system.","volume":"110","author":"Li","year":"2002","journal-title":"J Clin Invest."},{"key":"B34","doi-asserted-by":"publisher","first-page":"g3656","DOI":"10.1136\/bmj.g3656","article-title":"Vitamin D and mortality: meta-analysis of individual participant data from a large consortium of cohort studies from Europe and the United States.","volume":"348","author":"Schottker","year":"2014","journal-title":"BMJ."},{"key":"B35","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3390\/children7110241","article-title":"Association of vitamin D status and physical activity with lipid profile in Korean children and adolescents: a population-based study.","volume":"7","author":"Song","year":"2020","journal-title":"Children."},{"key":"B36","doi-asserted-by":"publisher","first-page":"366","DOI":"10.3390\/nu10030366","article-title":"Vitamin D, hypercalciuria and kidney stones.","volume":"10","author":"Letavernier","year":"2018","journal-title":"Nutrients."}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2022.970467\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T05:07:13Z","timestamp":1662095233000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2022.970467\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,2]]},"references-count":36,"alternative-id":["10.3389\/fnut.2022.970467"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2022.970467","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,2]]},"article-number":"970467"}}